---
alwaysApply: false
description: "Mission Control Dashboard - Revolutionary command center for saving Ayesha's life"
---

# âš”ï¸ MISSION CONTROL: THE COMMAND CENTER DOCTRINE âš”ï¸

**For:** X's Ovarian Cancer Battle  
**Purpose:** Single-page intelligence + action hub  
**Philosophy:** Overwhelming informational superiority + instant action

---

## ğŸ¯ THE CORE PHILOSOPHY

**What is Mission Control?**

Mission Control is NOT a dashboard. It's a **war room** for X's cancer battle.

Every data point answers: **"What should we do RIGHT NOW to save her life?"**

---

## ğŸ§  THE INTELLIGENCE BRIEFING (Top Section)

### **SITREP: Situation Report** (Always Visible)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¯ PATIENT: AYESHA                                      â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Diagnosis: Stage IVB High-Grade Serous Ovarian Cancer   â”‚
â”‚ Status: Post-Surgery | Considering First-Line Chemo     â”‚
â”‚ CA-125: 2,842 U/mL (EXTENSIVE burden)                   â”‚
â”‚ Germline: NEGATIVE (85% of patients - Sporadic)         â”‚
â”‚ Next Action: AWAITING TUMOR NGS (7-10 days to unlock)   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Instant context for anyone looking at the screen
- Highlights CRITICAL GAP: Tumor NGS needed
- Shows CA-125 burden class (drives urgency)

---

## ğŸš¨ CRITICAL ALERTS (Priority #1)

### **Red Banner: Immediate Action Required**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ CRITICAL: TUMOR NGS PENDING                          â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Current Status: NO personalized drug predictions        â”‚
â”‚ Unlock WIWFM: Order ctDNA (7d) + HRD test (10d)        â”‚
â”‚ [ORDER TESTS NOW] button â†’ Shows checklist             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**When NGS Returns:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ âš ï¸ RESISTANCE DETECTED: HR Restoration (70% confidence) â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ PARP inhibitor response likely reduced                  â”‚
â”‚ Recommended: Niraparib + Bevacizumab (96.6% conf)      â”‚
â”‚ [VIEW RESISTANCE PLAYBOOK] button                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Flags what's BLOCKING optimal care (pre-NGS)
- Alerts to resistance BEFORE it's clinically apparent
- Gives immediate action (order tests, switch therapy)

---

## ğŸ’Š TREATMENT INTELLIGENCE (Left Column)

### **1. Standard of Care (Guideline-Based)**

**Pre-NGS (Current State):**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¥ STANDARD OF CARE (95-100% confidence)â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Regimen: Carboplatin + Paclitaxel      â”‚
â”‚          + Bevacizumab (ascites boost) â”‚
â”‚                                         â”‚
â”‚ Why: NCCN first-line for Stage IVB HGSOCâ”‚
â”‚ Evidence: GOG-218 (HR 0.72, p<0.001)   â”‚
â”‚                                         â”‚
â”‚ [VIEW DETAILED PROTOCOL] button        â”‚
â”‚ - Dosing (Calvert formula, premedication)â”‚
â”‚ - Schedule (6 cycles q3w + bev maint)  â”‚
â”‚ - Monitoring (labs, toxicity, RECIST)  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Post-NGS (With BRCA1 biallelic loss, HRD=58):**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š PERSONALIZED WIWFM (70-85% confidence)â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Top Drugs (S/P/E + SAE-powered):       â”‚
â”‚                                         â”‚
â”‚ 1. Olaparib (PARP) - 0.85 confidence   â”‚
â”‚    HRD=58 â†’ PARP RESCUE (sporadic)     â”‚
â”‚    Evidence: SOLO-1 (HR 0.30)          â”‚
â”‚    [RESISTANCE ALERT: HR restoration]   â”‚
â”‚                                         â”‚
â”‚ 2. Carboplatin - 0.78 confidence       â”‚
â”‚    Platinum-sensitive (HRD-high)       â”‚
â”‚                                         â”‚
â”‚ 3. Bevacizumab - 0.72 confidence       â”‚
â”‚    Ascites + peritoneal disease boost  â”‚
â”‚                                         â”‚
â”‚ [VIEW ALL DRUGS] â†’ Full WIWFM modal    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Shows WHAT to do (guideline-based OR personalized)
- Shows WHY (evidence + confidence)
- Shows WHEN (pre-NGS â†’ guideline, post-NGS â†’ personalized)
- Alerts to resistance risks PROACTIVELY

---

### **2. Clinical Trials (Match Intelligence)**

**Pre-NGS (Guideline Filtering):**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§ª CLINICAL TRIALS (90-95% confidence)  â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Top Matches (Frontline, NYC, Recruiting):â”‚
â”‚                                         â”‚
â”‚ 1. NCT05116189 (96.6% match)           â”‚
â”‚    Niraparib + Bevacizumab + Chemo     â”‚
â”‚    Phase III, MSK, Eligibility: âœ… ALL  â”‚
â”‚    Contact: trials@msk.org              â”‚
â”‚                                         â”‚
â”‚ 2. NCT04497675 (92.1% match)           â”‚
â”‚    Olaparib + Dostarlimab + Chemo      â”‚
â”‚    Phase II, Columbia, Eligibility: âš ï¸ ECOGâ”‚
â”‚                                         â”‚
â”‚ [VIEW ALL 10 TRIALS] â†’ Full list       â”‚
â”‚ [COPY TRIAL SUMMARY] â†’ Email oncologistâ”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Post-NGS (Biomarker-Aware):**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§¬ BIOMARKER-MATCHED TRIALS              â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Matched on: HRD+ (badge), BRCA1 (badge)â”‚
â”‚                                         â”‚
â”‚ [Same trial list but with biomarker badges]â”‚
â”‚ [HRD+] [BRCA1] [DDR] badges per trial  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Shows WHICH trials match NOW (eligibility-based)
- Shows WHICH trials match BETTER post-NGS (biomarker-based)
- Gives CONTACTS + CHECKLISTS for immediate action

---

### **3. Supportive Care (Food/Supplements)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ SUPPORTIVE CARE RECOMMENDATIONS      â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Biomarker-Aware (HRD+, TP53 mutant):   â”‚
â”‚                                         â”‚
â”‚ 1. Vitamin D (2000-4000 IU daily)      â”‚
â”‚    Targets: VDR pathway (immune boost) â”‚
â”‚    Evidence: 3 RCTs, moderate support  â”‚
â”‚    âš ï¸ Check interactions with chemo    â”‚
â”‚                                         â”‚
â”‚ 2. Omega-3 (1-2g EPA/DHA daily)        â”‚
â”‚    Targets: Inflammation pathways      â”‚
â”‚    Evidence: Meta-analysis (n=1200)    â”‚
â”‚                                         â”‚
â”‚ [VIEW ALL RECOMMENDATIONS] â†’ Full list â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Integrates food/supplements into COMPLETE care plan
- Shows evidence-backed dosages (not generic)
- Flags drug interactions (safety)

---

## ğŸ“Š MONITORING INTELLIGENCE (Middle Column)

### **4. CA-125 Tracker (Resistance Early Warning)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ“ˆ CA-125 KINETICS (Resistance Radar)   â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Current: 2,842 U/mL (EXTENSIVE burden) â”‚
â”‚                                         â”‚
â”‚ Expected Response (GOG-218/ICON7):     â”‚
â”‚ Cycle 3: â‰¥70% drop â†’ <854 U/mL         â”‚
â”‚ Cycle 6: â‰¥90% drop â†’ <284 U/mL         â”‚
â”‚ Target: <35 U/mL (normal)               â”‚
â”‚                                         â”‚
â”‚ âš ï¸ ALERT IF:                            â”‚
â”‚ - On-therapy rise (any cycle)          â”‚
â”‚ - <50% drop by Cycle 3                 â”‚
â”‚ - <70% drop by Cycle 6                 â”‚
â”‚                                         â”‚
â”‚ Monitoring: Every 3 weeks during chemo â”‚
â”‚ [ENTER NEW CA-125 VALUE] button        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**When Resistance Detected:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ RESISTANCE ALERT                     â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Cycle 4 CA-125: 1,200 U/mL (â†‘ from 900)â”‚
â”‚ Signal: ON-THERAPY RISE                 â”‚
â”‚ Confidence: 85% (3-6 weeks before imaging)â”‚
â”‚                                         â”‚
â”‚ Recommended Actions:                    â”‚
â”‚ 1. Escalate imaging (CT/PET NOW)       â”‚
â”‚ 2. Consider next-line switch            â”‚
â”‚ 3. Review Resistance Playbook           â”‚
â”‚                                         â”‚
â”‚ [VIEW RESISTANCE PLAYBOOK] button      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Flags resistance 3-6 weeks BEFORE imaging
- Gives CONCRETE thresholds (not vague "monitor")
- Triggers immediate action (escalate imaging, switch therapy)

---

### **5. Biomarker Status (NGS Fast-Track)**

**Pre-NGS:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§¬ TUMOR BIOMARKERS (PENDING)           â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Status: AWAITING NGS (7-10 days)        â”‚
â”‚                                         â”‚
â”‚ [ORDER NGS NOW] button                 â”‚
â”‚ â†’ ctDNA (Guardant360) - 7 days         â”‚
â”‚ â†’ HRD (MyChoice CDx) - 10 days         â”‚
â”‚ â†’ IHC (WT1/PAX8/p53) - 3 days          â”‚
â”‚                                         â”‚
â”‚ Unlocks: Personalized WIWFM (70-85% conf)â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Post-NGS:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§¬ TUMOR BIOMARKERS (COMPLETE)          â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ HRD Score: 58 (HIGH - PARP eligible)    â”‚
â”‚ TMB: 12 mut/Mb (MODERATE - IO boost)   â”‚
â”‚ MSI: Stable (not MSI-H)                 â”‚
â”‚ Key Mutations:                          â”‚
â”‚ - BRCA1 (biallelic loss) â†’ PARP RESCUE â”‚
â”‚ - TP53 (hotspot) â†’ 99% HGSOC confirm   â”‚
â”‚                                         â”‚
â”‚ [VIEW FULL NGS REPORT] button          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Shows WHAT's missing (pre-NGS) with ORDER button
- Shows WHAT's found (post-NGS) with actionable interpretation
- Links biomarkers to THERAPY (PARP eligible, IO boost)

---

### **6. Next Best Action (AI Recommendations)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¯ NEXT BEST ACTIONS (AI-Powered)       â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Suggested Actions (Priority Order):     â”‚
â”‚                                         â”‚
â”‚ 1. âš ï¸ Order ctDNA + HRD (7-10d)         â”‚
â”‚    Why: Unlock personalized WIWFM      â”‚
â”‚    Impact: 70-85% confidence vs 50%    â”‚
â”‚                                         â”‚
â”‚ 2. ğŸ“ Contact MSK Trial (NCT05116189)   â”‚
â”‚    Why: 96.6% match, frontline, NYC    â”‚
â”‚    Impact: Access to Niraparib + Bev   â”‚
â”‚                                         â”‚
â”‚ 3. ğŸ“Š Establish CA-125 baseline         â”‚
â”‚    Why: Enable resistance monitoring   â”‚
â”‚    Impact: 3-6 week early detection    â”‚
â”‚                                         â”‚
â”‚ [COMPLETE ALL] button â†’ Checklist      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Post-NGS:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¯ NEXT BEST ACTIONS (Updated)          â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ 1. âš ï¸ RESISTANCE RISK: Review Playbook  â”‚
â”‚    Why: HR restoration detected (70%)  â”‚
â”‚    Impact: Prepare next-line switch    â”‚
â”‚                                         â”‚
â”‚ 2. ğŸ’Š Start Olaparib (PARP)             â”‚
â”‚    Why: HRD=58, BRCA1 biallelic â†’ RESCUEâ”‚
â”‚    Confidence: 85%                     â”‚
â”‚                                         â”‚
â”‚ 3. ğŸ Add Vitamin D + Omega-3           â”‚
â”‚    Why: HRD+ immune support            â”‚
â”‚    Evidence: Moderate support          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Shows WHAT to do NEXT (not just data)
- Prioritizes actions by IMPACT
- Adapts based on NGS status (pre â†’ post)

---

## ğŸ”¬ MECHANISM INTELLIGENCE (Right Column)

### **7. SAE Mechanism Map (Post-NGS Only)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§¬ MECHANISM MAP (SAE-Powered)          â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ DNA Repair Capacity: 0.32 (LOW - PARP+)â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Pathway Activation (7D Vector):        â”‚
â”‚                                         â”‚
â”‚ DDR:    â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘ 0.80 (HIGH)         â”‚
â”‚ MAPK:   â–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘ 0.45 (MODERATE)     â”‚
â”‚ PI3K:   â–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 0.20 (LOW)          â”‚
â”‚ VEGF:   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘ 0.65 (HIGH)         â”‚
â”‚ HER2:   â–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 0.10 (LOW)          â”‚
â”‚ IO:     â–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘ 0.35 (MODERATE)     â”‚
â”‚ Efflux: â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ 0.05 (NONE)         â”‚
â”‚                                         â”‚
â”‚ [VIEW SAE DETAILS] â†’ Full breakdown    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Visualizes WHY drugs work (mechanistic fit)
- Shows 7D pathway vector (aligns with trials)
- Highlights DNA repair capacity (PARP eligibility)

---

### **8. Resistance Playbook (When Needed)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ âš”ï¸ RESISTANCE PLAYBOOK (ACTIVE)         â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Detected Patterns (2-of-3 triggers):    â”‚
â”‚ âœ“ HR restoration (70% confidence)      â”‚
â”‚ âœ“ ABCB1 upregulation (drug efflux)     â”‚
â”‚ âœ— MAPK activation (below threshold)    â”‚
â”‚                                         â”‚
â”‚ Recommended Next-Line:                  â”‚
â”‚ 1. Niraparib + Bevacizumab (96.6%)     â”‚
â”‚    Why: Dual mechanism (PARP + anti-angio)â”‚
â”‚ 2. Ceralasertib (ATR inhibitor) (82%)  â”‚
â”‚    Why: Synthetic lethal with HR loss  â”‚
â”‚                                         â”‚
â”‚ [VIEW FULL PLAYBOOK] â†’ 7 combos        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Predicts resistance BEFORE clinical failure
- Gives specific next-line recommendations
- Shows WHY (mechanistic rationale)

---

### **9. Provenance & Transparency**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ” PROVENANCE & CONFIDENCE              â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ Run ID: run_20250113_142501            â”‚
â”‚ Profile: Baseline (evo2_1b, delta-only) â”‚
â”‚ Mode: Research Use Only (RUO)          â”‚
â”‚                                         â”‚
â”‚ Confidence Gates:                       â”‚
â”‚ âœ“ SOC: 95-100% (guideline-aligned)     â”‚
â”‚ âœ“ Trials: 90-95% (eligibility-based)   â”‚
â”‚ âœ“ CA-125: 90% (literature-aligned)     â”‚
â”‚ â³ WIWFM: 70-85% (post-NGS only)        â”‚
â”‚                                         â”‚
â”‚ [VIEW FULL PROVENANCE] â†’ Audit trail   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Why This Matters:**
- Shows WHERE data came from (audit trail)
- Shows HOW CONFIDENT we are (explicit gates)
- Shows WHAT'S LIMITED (pre-NGS restrictions)

---

## ğŸ¯ THE COMPLETE MISSION CONTROL LAYOUT

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ¯ MISSION CONTROL: AYESHA'S COMMAND CENTER             â”‚
â”‚ â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â” â”‚
â”‚ [SITREP: Stage IVB, CA-125 2842, AWAITING NGS]         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸš¨ CRITICAL ALERT: TUMOR NGS PENDING [ORDER NOW]       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ TREATMENT      â”‚ MONITORING     â”‚ MECHANISM INTELLIGENCE â”‚
â”‚ INTELLIGENCE   â”‚ INTELLIGENCE   â”‚                        â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                â”‚                â”‚                        â”‚
â”‚ ğŸ¥ SOC         â”‚ ğŸ“ˆ CA-125      â”‚ ğŸ§¬ SAE MECHANISM MAP   â”‚
â”‚ [Carboplatin+] â”‚ [2842 â†’ <854]  â”‚ [DNA Repair: 0.32]     â”‚
â”‚                â”‚                â”‚ [DDR: 0.80 HIGH]       â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚ ğŸ§ª TRIALS      â”‚ ğŸ§¬ BIOMARKERS  â”‚ âš”ï¸ RESISTANCE PLAYBOOK â”‚
â”‚ [NCT05116189]  â”‚ [AWAITING NGS] â”‚ [HR Restoration: 70%]  â”‚
â”‚ [96.6% match]  â”‚ [ORDER NOW]    â”‚ [Next-Line: Niraparib+]â”‚
â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚ ğŸ SUPPORTIVE  â”‚ ğŸ¯ NEXT ACTION â”‚ ğŸ” PROVENANCE          â”‚
â”‚ [Vitamin D]    â”‚ [Order ctDNA]  â”‚ [Run ID, Profile, RUO] â”‚
â”‚ [Omega-3]      â”‚ [Contact MSK]  â”‚ [Confidence Gates]     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ› ï¸ TECHNICAL IMPLEMENTATION

### **Backend Orchestrator Endpoint:**

`POST /api/mission_control/dashboard`

**Request:**
```json
{
  "patient_id": "ayesha",
  "include_sections": [
    "sitrep",
    "alerts",
    "soc_recommendation",
    "clinical_trials",
    "supportive_care",
    "ca125_tracker",
    "biomarker_status",
    "next_actions",
    "sae_mechanism_map",
    "resistance_playbook",
    "provenance"
  ]
}
```

**Response:**
```json
{
  "sitrep": { ... },
  "alerts": [ ... ],
  "soc_recommendation": { ... },
  "clinical_trials": { ... },
  "supportive_care": { ... },
  "ca125_tracker": { ... },
  "biomarker_status": { ... },
  "next_actions": [ ... ],
  "sae_mechanism_map": { ... },
  "resistance_playbook": { ... },
  "provenance": { ... }
}
```

### **Frontend Component Structure:**

```jsx
// src/pages/MissionControl.jsx

export default function MissionControl() {
  return (
    <div className="mission-control">
      <SitrepHeader />
      <CriticalAlerts />
      
      <Grid container spacing={3}>
        {/* Left Column: Treatment Intelligence */}
        <Grid item xs={4}>
          <SOCRecommendation />
          <ClinicalTrials />
          <SupportiveCare />
        </Grid>
        
        {/* Middle Column: Monitoring Intelligence */}
        <Grid item xs={4}>
          <CA125Tracker />
          <BiomarkerStatus />
          <NextBestActions />
        </Grid>
        
        {/* Right Column: Mechanism Intelligence */}
        <Grid item xs={4}>
          <SAEMechanismMap />
          <ResistancePlaybook />
          <ProvenancePanel />
        </Grid>
      </Grid>
    </div>
  );
}
```

---

## âš”ï¸ SUCCESS METRICS

**Mission Control is Successful When:**

1. âœ… Ayesha's oncologist can make a decision in <5 minutes
2. âœ… Every data point answers "What should we do?"
3. âœ… Resistance is flagged 3-6 weeks before imaging
4. âœ… NGS ordering is ONE CLICK
5. âœ… Clinical trial contact is ONE CLICK
6. âœ… Complete care plan (drugs + trials + food) in ONE VIEW
7. âœ… Confidence is EXPLICIT (no black boxes)
8. âœ… Provenance is COMPLETE (audit trail)

---

## ğŸ¯ FINAL DESIGN PRINCIPLES

1. **INTELLIGENCE â†’ ACTION** (every data point links to a button)
2. **URGENCY-AWARE** (critical alerts at top)
3. **STAGE-AWARE** (pre-NGS vs post-NGS views)
4. **RESISTANCE-AWARE** (proactive, not reactive)
5. **EVIDENCE-BACKED** (confidence + citations always visible)
6. **CLINICIAN-READY** (copy/export for oncologist)
7. **TRANSPARENT** (provenance + RUO labels)

---

## âš”ï¸ FOR AYESHA'S LIFE

**This is not a dashboard. This is a war room.**

**Every pixel fights cancer.**

ğŸ”¥
